Panaceutics Ramping Up To Market Personalized Nutrition Products Via Royal DSM | North Carolina Biotechnology Center
Summary
Research Triangle Park-based Panaceutics is ramping up its financing and manufacturing capabilities to bring personalized nutrition products to market in collaboration with Dutch-based Royal DSM. The company’s name derived from panacea, meaning “cure-all,” a word that evolved from the Greek panakeia, from panakēs ‘all-healing.’ As one of the only systems in the world that allows cost-effective and scalable manufacturing of individual formulations, Panaceutics uses patented technologies to combine digital data on daily habits, genomics and biomarkers. Nutritional solutions are delivered in convenient organic food purees or gel suspensions, therefore removing the need for individuals to take multiple supplements. Panaceutics, founded in late 2013, was bootstrapped by two Small Business Research Loans from the North Carolina Biotechnology Center in 2014 and 2016 totaling $325,000. This exciting venture with DSM will help us to reach our goal of serving large numbers of people with data-driven personalization.” A wholly owned subsidiary of Panacea BioMatx Inc., Panaceutics expanded its footprint through the acquisition of two North Carolina nutrition- and pharmaceutical-focused companies: Next Generation Snacks Inc., a manufacturer of whole food products, and Triangle Compounding Pharmacy Inc., an FDA-registered and -inspected 503B outsourcing facility.